Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DSGB vs PENG+LFCN for Postoperative Analgesia After Hip Arthroplasty
NCT07770932Recruiting
- Sponsor
- Istanbul Medipol University
- Start
- Aug 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Istanbul Medipol University. Primary endpoint: Cumulative Postoperative Opioid Consumption at 24 hours. Started Aug 2026; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07770932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07770932.